Cubist Systematic Strategies, LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 101 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is 1.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$1,718,713
-3.8%
63,964
+27.7%
0.01%
+8.3%
Q2 2023$1,786,031
-19.0%
50,085
-7.9%
0.01%
-7.7%
Q4 2022$2,205,815
+189.5%
54,384
+135.8%
0.01%
+225.0%
Q3 2022$762,000
-62.3%
23,063
-59.8%
0.00%
-66.7%
Q2 2022$2,020,000
-60.5%
57,380
-48.4%
0.01%
-72.1%
Q1 2022$5,119,000
+212.5%
111,303
+350.5%
0.04%
+168.8%
Q4 2021$1,638,000
+304.4%
24,709
+280.8%
0.02%
+220.0%
Q3 2021$405,000
-92.3%
6,489
-89.8%
0.01%
-91.5%
Q2 2021$5,276,000
+98.4%
63,703
+58.9%
0.06%
+73.5%
Q1 2021$2,659,000
+522.7%
40,092
+619.7%
0.03%
+466.7%
Q4 2020$427,000
-22.5%
5,571
-56.5%
0.01%
-25.0%
Q3 2020$551,000
+56.5%
12,806
+57.1%
0.01%
+33.3%
Q2 2020$352,000
-32.4%
8,154
-55.0%
0.01%
-57.1%
Q1 2020$521,000
-80.4%
18,118
-56.7%
0.01%
-71.4%
Q4 2019$2,654,000
+182.6%
41,849
+25.7%
0.05%
+157.9%
Q3 2019$939,000
-26.3%
33,306
-30.7%
0.02%
-17.4%
Q2 2019$1,274,000
+359.9%
48,062
+218.2%
0.02%
+155.6%
Q1 2019$277,000
+15.4%
15,104
-21.7%
0.01%
-18.2%
Q4 2018$240,000
-1.6%
19,289
+7.5%
0.01%
-8.3%
Q2 2018$244,000
+771.4%
17,941
+365.6%
0.01%
+500.0%
Q3 2016$28,000
+3.7%
3,853
-23.3%
0.00%0.0%
Q2 2016$27,0005,0240.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q3 2016
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders